CCL21/CCR7 prevents apoptosis via the ERK pathway in human non-small cell lung cancer cells

PLoS ONE

Volumn 7, Issue 3, 2012, Pages

  Xu, Ying ^a   Liu, Lifeng ^a   Qiu, Xueshan ^a   Liu, Zihui ^a   Li, Haiying ^a   Li, Zixuan ^a   Luo, Wenting ^a   Wang, Enhua ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; CASPASE 3; CHEMOKINE RECEPTOR CCR7; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN BAX; PROTEIN BCL 2; SECONDARY LYMPHOID TISSUE CHEMOKINE; SMALL INTERFERING RNA; BAX PROTEIN, HUMAN; CASP3 PROTEIN, HUMAN; CCL21 PROTEIN, HUMAN; CCR7 PROTEIN, HUMAN; MESSENGER RNA; RNA;

APOPTOSIS; ARTICLE; CANCER CELL; CELL PROTECTION; CONTROLLED STUDY; DOWN REGULATION; ENZYME INHIBITION; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; LUNG NON SMALL CELL CANCER; PROTEIN PROTEIN INTERACTION; REAL TIME POLYMERASE CHAIN REACTION; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; UPREGULATION; WESTERN BLOTTING; DRUG ANTAGONISM; DRUG EFFECT; GENETICS; LUNG TUMOR; METABOLISM; NUCLEOTIDE SEQUENCE; PATHOLOGY; PHYSIOLOGY; PROTO ONCOGENE; TUMOR CELL LINE;

APOPTOSIS; BASE SEQUENCE; BCL-2-ASSOCIATED X PROTEIN; CARCINOMA, NON-SMALL-CELL LUNG; CASPASE 3; CELL LINE, TUMOR; CHEMOKINE CCL21; DOWN-REGULATION; GENES, BCL-2; HUMANS; LUNG NEOPLASMS; MAP KINASE SIGNALING SYSTEM; PROTO-ONCOGENE PROTEINS C-BCL-2; RECEPTORS, CCR7; RNA, MESSENGER; RNA, NEOPLASM; RNA, SMALL INTERFERING; UP-REGULATION;

EID: 84863375152     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0033262     Document Type: Article

References (48)

1. Muller A, Homey B, Soto N, Ge N, Catron D, et al. (2001) Involvement of chemokine receptors in breast cancer metastasis. Nature 410: 50-6.
2. Tachibana K, Hirota S, Iizasa H, Yoshida H, Kawabata K, et al. (1998) The chemokine receptor CXCR4 is essential for vascularization of the gastrointestinal tract. Nature 393: 591-4.
3. Zou YR, Kottmann AH, Kuroda M, Taniuchi I, Littmann DR, (1998) Function of the chemokine receptor CXCR4 in haematopoiesis and in cerebellar development. Nature 393: 595-9.
4. Wörnle M, Schmid H, Merkle M, Banas B, (2004) Effects of chemokines on proliferation and apoptosis of human mesangial cells. BMC Nephrol 5: 8.
5. Beider K, Abraham M, Begin M, Wald H, Weiss ID, et al. (2009) Interaction between CXCR4 and CCL20 pathways regulates tumor growth. PLoS One 4: e5125.
6. Murphy PM, Baggiolini M, Charo IF, Herbert CA, Horuk R, et al. (2000) International union of pharmacology. XXII. Nomenclature for chemokine receptors. Pharmacol Rev 52: 145-76.
7. Baggiolini M, (1998) Chemokines and leukocyte traffic. Nature 392: 565-8.
8. Zlotnik A, Yoshie O, (2000) Chemokines: a new classification system and their role in immunity. Immunity 12: 121-7.
9. Dieu MC, Vanbervliet B, Vicari A, Bridon JM, Oldham E, et al. (1998) Selective recruitment of immature and mature dendritic cells by distinct chemokines expressed in different anatomic sites. J Exp Med 188: 373-86.
10. Hirao M, Onai N, Hiroishi K, Watkins SC, Matsushima K, et al. (2000) CC chemokine receptor-7 on dendritic cells is induced after interaction with apoptotic tumor cells: critical role in migration from the tumor site to draining lymph nodes. Cancer Res 60: 2209-17.
11. Sozzani S, Allavena P, D'Amico G, Luini W, Bianchi G, et al. (1998) Differential regulation of chemokine receptors during dendritic cell maturation: a model for their trafficking properties. J Immunol 161: 1083-6.
12. Li Y, Qiu X, Zhang S, Zhang Q, Wang E, (2009) Hypoxia induced CCR7 expression via HIF-1alpha and HIF-2alpha correlates with migration and invasion in lung cancer cells. Cancer Biol Ther 8: 322-30.
13. Xu Y, Liu L, Qiu X, Jiang L, Huang B, et al. (2011) CCL21/CCR7 promotes G2/M phase progression via the ERK pathway in human non-small cell lung cancer cells. PLoS One 6: e21119.
14. Aliaga JC, Deschênes C, Beaulieu JF, Calvo EL, Rivard N, (1999) Requirement of the MAP kinase cascade for cell cycle progression and differentiation of human intestinal cells. Am J Physiol 277: 631-41.
15. Widmann C, Gibson S, Jarpe MB, Johnson GL, (1999) Mitogen-activated protein kinase: conservation of a three-kinase module from yeast to human. Physiol Rev 79: 143-80.
16. Puddicombe SM, Davies DE, (2000) The role of MAP kinases in intracellular signal transduction in bronchial epithelium. Clin Exp Allergy 30: 7-11.
17. Saxena M, Mustelin T, (2000) Extracellular signals and scores of phosphatases: all roads lead to MAP kinase. Semin Immunol 12: 387-96.
18. Wu S, Xing W, Peng J, Yuan X, Zhao X, et al. (2008) Tumor transfected with CCL21 enhanced reactivity and apoptosis resistance of human monocyte-derived dendritic cells. Immunobiology 213: 417-26.
19. Ling YH, Liebes L, Jiang JD, Holland JF, Elliott PJ, et al. (2003) Mechanisms of proteasome inhibitor PS-341-induced G(2)-M-phase arrest and apoptosis in human non-small cell lung cancer cell lines. Clin Cancer Res 9: 1145-54.
20. Kim JW, Ferris RL, Whiteside TL, (2005) Chemokine C receptor 7 expression and protection of circulating CD8+ T lymphocytes from apoptosis. Clin Cancer Res 11: 7901-10.
21. Wei MC, Zong WX, Cheng EH, Lindsten T, Panoutsakopoulou V, et al. (2001) Proapoptotic BAX and BAK: a requisite gateway to mitochondrial dysfunction and death. Science 292: 727-30.
22. Ewings KE, Wiggins CM, Cook SJ, (2007) Bim and the pro-survival Bcl-2 proteins: opposites attract, ERK repels. Cell Cycle 6: 2236-40.
23. Cory S, Adams JM, (2002) The Bcl2 family: regulators of the cellular life-or-death switch. Nat Rev Cancer 2: 647-56.
24. Strasser A, (2005) The role of BH3-only proteins in the immune system. Nat Rev Immunol 5: 189-200.
25. Adams JM, Cory S, (1998) The Bcl-2 protein family: arbiters of cell survival. Science 281: 1322-6.
26. Antonsson B, Martinou JC, (2000) The Bcl-2 protein family. Exp Cell Res 256: 50-7.
27. Salvesen GS, Dixit VM, (1997) Caspases: intracellular signaling by proteolysis. Cell 91: 443-6.
28. Banas B, Wörnle M, Merkle M, Gonzalez-Rubio M, Schmid H, et al. (2004) Binding of the chemokine SLC/CCL21 to its receptor CCR7 increases adhesive properties of human mesangial cells. Kidney Int 66: 2256-63.
29. Kochetkova M, Kumar S, McColl SR, (2009) Chemokine receptors CXCR4 and CCR7 promote metastasis by preventing anoikis in cancer cells. Cell Death Differ 16: 664-73.
30. Ziegler E, Oberbarnscheidt M, Bulfone-Paus S, Förster R, Kunzendorf U, et al. (2007) CCR7 signaling inhibits T cell proliferation. J Immunol 179: 6485-93.
31. Yamada Y, Ando F, Shimokata H, (2006) Association of polymorphisms in forkhead box C2 and perilipin genes with bone mineral density in community-dwelling Japanese individuals. Int J Mol Med 18: 119-27.
32. Wang J, Zhang X, Thomas SM, Grandis JR, Wells A, et al. (2005) Chemokine receptor 7 activates phosphoinositide-3 kinase-mediated invasive and prosurvival pathways in head and neck cancer cells independent of EGFR. Oncogene 24: 5897-904.
33. Li Z, Li J, Mo B, Hu C, Liu H, et al. (2008) Genistein induces G2/M cell cycle arrest via stable activation of ERK1/2 pathway in MDA-MB-231 breast cancer cells. Cell Biol Toxicol 24: 401-9.
34. Wu Y, Peng H, Cui M, Whitney NP, Huang Y, et al. (2009) CXCL12 increases human neural progenitor cell proliferation through Akt-1/FOXO3a signaling pathway. J Neurochem 109: 1157-67.
35. Sánchez-Sánchez N, Riol-Blanco L, de la Rosa G, Puig-Kröger A, García-Bordas J, et al. (2004) Chemokine receptor CCR7 induces intracellular signaling that inhibits apoptosis of mature dendritic cells. Blood 104: 619-25.
36. Jackson ML, Neuzil KM, Thompson WW, Shay DK, Yu O, et al. (2004) The burden of community-acquired pneumonia in seniors: results of a population-based study. Clin Infect Dis 39: 1642-50.
37. Escribano C, Delgado-Martín C, Rodríguez-Fernández JL, (2009) CCR7-dependent stimulation of survival in dendritic cells involves inhibition of GSK3beta. J Immunol 183: 6282-95.
38. Gollmer K, Asperti-Boursin F, Tanaka Y, Okkenhaug K, Vanhaesebroeck B, et al. (2009) CCL21 mediates CD4+ T-cell costimulation via a DOCK2/Rac-dependent pathway. Blood 114: 580-8.
39. Shannon LA, Calloway PA, Welch TP, Vines CM, (2010) CCR7/CCL21 migration on fibronectin is mediated by phospholipase Cgamma1 and ERK1/2 in primary T lymphocytes. J Biol Chem 285: 38781-7.
40. Iijima N, Yanagawa Y, Clingan JM, Onoé K, (2005) CCR7-mediated c-Jun N-terminal kinase activation regulates cell migration in mature dendritic cells. Int Immunol 17: 1201-12.
41. Liu FY, Zhao ZJ, Li P, Ding X, Zong ZH, et al. (2010) Mammalian target of rapamycin (mTOR) is involved in the survival of cells mediated by chemokine receptor 7 through PI3K/Akt in metastatic squamous cell carcinoma of the head and neck. Br J Oral Maxillofac Surg 48: 291-6.
42. Lee SJ, Park K, Ha SD, Kim WJ, Moon SK, (2010) Gleditsia sinensis thorn extract inhibits human colon cancer cells: the role of ERK1/2, G2/M-phase cell cycle arrest and p53 expression. Phytother Res 24: 1870-6.
43. Badr G, Borhis G, Treton D, Richard Y, (2005) IFN{alpha} enhances human B-cell chemotaxis by modulating ligand-induced chemokine receptor signaling and internalization. Int Immunol 17: 459-67.
44. Wegiel B, Bjartell A, Culig Z, Persson JL, (2008) Interleukin-6 activates PI3K/Akt pathway and regulates cyclin A1 to promote prostate cancer cell survival. Int J Cancer 122: 1521-9.
45. Liu L, Zhu Y, Xu Y, Reiter RJ, (2011) Prevention of ERK activation involves melatonin-induced G1 and G2/M phase arrest in the human osteoblastic cell line hFOB 1.19. J Pineal Res doi: 10.1111/j.1600-079X.2011.00971.x. [Epub ahead of print].
46. Liu L, Zhu Y, Xu Y, Reiter RJ, (2011) Melatonin delays cell proliferation by inducing G1 and G2/M phase arrest in a human osteoblastic cell line hFOB 1.19. J Pineal Res 50: 222-31.
47. Livak KJ, Schmittgen TD, (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25: 402-8.
48. Pizarro JG, Yeste-Velasco M, Esparza JL, Verdaguer E, Pallàs M, et al. (2008) The antiproliferative activity of melatonin in B65 rat dopaminergic neuroblastoma cells is related to the downregulation of cell cycle-related genes. J Pineal Res 45: 8-16.